Cash And Equivalent Изменить Дата
Abbott USD 7.84B 1.33B 2023-06
Acadia Pharmaceuticals USD 188.66M 90.46M 2023-12
Acorda Therapeutics USD 25.27M 4.98M 2023-06
Agios Pharmaceuticals USD 88.2M 23.87M 2023-12
Akebia Therapeutics USD 42.92M 3.6M 2023-12
Alnylam Pharmaceuticals USD 812.69M 220.34M 2023-12
AstraZeneca USD 4.87B 793M 2023-09
BioMarin Pharmaceutical USD 755.13M 30.29M 2023-12
Bluebird Bio USD 165.35M 7.52M 2023-09
Eli Lilly USD 2.38B 313.7M 2023-09
Esperion Therapeutics USD 114.83M 23.64M 2023-09
Halozyme Therapeutics USD 118.37M 155.86M 2023-12
Illumina USD 1.05B 121M 2023-12
Insmed USD 482.37M 4.74M 2023-12
Ironwood Pharmaceuticals USD 92.15M 18.01M 2023-12
J&J USD 3.5B 497M 2023-09
Lexicon Pharmaceuticals USD 21.12M 235.62M 2023-09
MannKind USD 238.48M 155.46M 2023-12
Merck USD 8.6B 2.94B 2023-09
Moderna USD 2.91B 25M 2023-12
PTC Therapeutics USD 594M 428.84M 2023-12
Regulus Therapeutics USD 25.83M 11.43M 2023-09
Sarepta Therapeutics USD 541.93M 310M 2023-09
Thermo Fisher Scientific USD 8.08B 1.93B 2023-12
Ultragenyx Pharmaceutical USD 777.11M 704.54M 2023-12
United Therapeutics USD 1.21B 100M 2023-12
Vanda Pharmaceuticals USD 150.03M 204.14M 2023-06



Lexicon Pharmaceuticals Денежные Средства И Эквиваленты - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2024.